Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND POU5F1, MGC22487, 5460, ENSG00000230336, POU5F1P1, OTF3P1, Oct4, OCT4, OCT3, OTF3C, OTF4, OTF3 AND Prognosis
36 results:

  • 1. Metastases and treatment-resistant lineages in patient-derived cancer cells of colorectal cancer.
    Fujino S; Miyoshi N; Ito A; Hayashi R; Yasui M; Matsuda C; Ohue M; Horie M; Yachida S; Koseki J; Shimamura T; Hata T; Ogino T; Takahashi H; Uemura M; Mizushima T; Doki Y; Eguchi H
    Commun Biol; 2023 Nov; 6(1):1191. PubMed ID: 37996567
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Furanocoumarin Notopterol: Inhibition of Hepatocellular Carcinogenesis through Suppression of cancer Stemness Signaling and Induction of Oxidative Stress-Associated Cell Death.
    Huang TY; Yang CK; Chen MY; Yadav VK; Fong IH; Yeh CT; Cherng YG
    Nutrients; 2023 May; 15(11):. PubMed ID: 37299411
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Modulation of rectal cancer stemness, patient outcome and therapy response by adipokines.
    Marques V; Ourô S; Afonso MB; Rodrigues CMP
    J Physiol Biochem; 2023 May; 79(2):261-272. PubMed ID: 36495464
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. FK866 inhibits colorectal cancer metastasis by reducing NAD
    Xie H; Lei Y; Mao Y; Lan J; Yang J; Quan H; Zhang T
    Genes Genomics; 2022 Dec; 44(12):1531-1541. PubMed ID: 36214983
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Targeting TROY-mediated P85a/AKT/TBX3 signaling attenuates tumor stemness and elevates treatment response in hepatocellular carcinoma.
    Liu B; Fang X; Kwong DL; Zhang Y; Verhoeft K; Gong L; Zhang B; Chen J; Yu Q; Luo J; Tang Y; Huang T; Ling F; Fu L; Yan Q; Guan XY
    J Exp Clin Cancer Res; 2022 May; 41(1):182. PubMed ID: 35610614
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. miR-3065-3p promotes stemness and metastasis by targeting CRLF1 in colorectal cancer.
    Li Y; Xun J; Wang B; Ma Y; Zhang L; Yang L; Gao R; Guan J; Liu T; Gao H; Wang X; Zhang Q
    J Transl Med; 2021 Oct; 19(1):429. PubMed ID: 34656128
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Atypical cyclin P regulates cancer cell stemness through activation of the WNT pathway.
    Sánchez-Botet A; Quandt E; Masip N; Escribá R; Novellasdemunt L; Gasa L; Li VSW; Raya Á; Clotet J; Ribeiro MPC
    Cell Oncol (Dordr); 2021 Dec; 44(6):1273-1286. PubMed ID: 34604945
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. High Expression of Stem Cell-Related Genes in Polyps with Villous Features and High-Grade Dysplasia Support Malignant Phenotype and colorectal Carcinogenesis.
    Sahin I; Gündoğdu B; Ceylan AC; Erdem HB; Tatar A
    Asian Pac J Cancer Prev; 2021 Aug; 22(8):2429-2435. PubMed ID: 34452555
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. LncRNA KLK8 modulates stem cell characteristics in colon cancer.
    Wang K; Song W; Shen Y; Wang H; Fan Z
    Pathol Res Pract; 2021 Aug; 224():153437. PubMed ID: 34271345
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. USP47 maintains the stemness of colorectal cancer cells and is inhibited by parthenolide.
    Zhang S; Ju X; Yang Q; Zhu Y; Fan D; Su G; Kong L; Li Y
    Biochem Biophys Res Commun; 2021 Jul; 562():21-28. PubMed ID: 34030041
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A comprehensive assessment of the impact of a colorectal cancer screening program in a northern Italian area.
    Pancheri S; Pertile R; Armelao F; Rizzello RV; Piffer S; Zorzi M; Guzzinati S; Ferro A; Mantovani W; de Pretis G
    Dig Liver Dis; 2022 Mar; 54(3):400-406. PubMed ID: 33853757
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Nicotine-derived NNK induces the stemness enrichment of CRC cells through regulating the balance of DUSP4-ERK1/2 feedback loop.
    Chen Y; Wang Q; Cao L; Tang Y; Yao M; Bi H; Huang Y; Sun G; Song J
    Ecotoxicol Environ Saf; 2021 May; 214():112057. PubMed ID: 33662786
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Crenolanib Regulates ERK and AKT/mTOR Signaling Pathways in RAS/BRAF-Mutated colorectal cancer Cells and Organoids.
    Fujino S; Miyoshi N; Ito A; Yasui M; Ohue M; Ogino T; Takahashi H; Uemura M; Matsuda C; Mizushima T; Doki Y; Eguchi H
    Mol Cancer Res; 2021 May; 19(5):812-822. PubMed ID: 33579816
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Prognostic value of oct4 in colorectal cancer: analysis using immunohistochemistry and bioinformatics validation.
    Fang W; Ni M; Zhang M; Chen H
    Biomark Med; 2020 Oct; 14(15):1473-1484. PubMed ID: 33185466
    [No Abstract]    [Full Text] [Related]  

  • 15. Prognostic implication of SOX2 expression in small intestinal adenocarcinoma.
    Kim JW; Chung JY; Ylaya K; Park Y; Jun SY; Hong SM; Hewitt SM
    Virchows Arch; 2021 Jun; 478(6):1049-1060. PubMed ID: 33103210
    [TBL] [Abstract] [Full Text] [Related]  

  • 16.
    Bhattacharya A; Mukherjee S; Khan P; Banerjee S; Dutta A; Banerjee N; Sengupta D; Basak U; Chakraborty S; Dutta A; Chattopadhyay S; Jana K; Sarkar DK; Chatterjee S; Das T
    Sci Signal; 2020 Oct; 13(654):. PubMed ID: 33082288
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Prognostic value of octamer binding transcription factor 4 for patients with solid tumors: A meta-analysis.
    Zhao X; Lu H; Sun Y; Liu L; Wang H
    Medicine (Baltimore); 2020 Oct; 99(42):e22804. PubMed ID: 33080755
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Intrafractional vaginal dilation in anal cancer patients undergoing pelvic radiotherapy (DILANA) - a prospective, randomized, 2-armed phase-II-trial.
    Arians N; Häfner M; Krisam J; Lang K; Wark A; Koerber SA; Hommertgen A; Debus J
    BMC Cancer; 2020 Jan; 20(1):52. PubMed ID: 31964381
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. RBCK1 contributes to chemoresistance and stemness in colorectal cancer (CRC).
    Liu ML; Zang F; Zhang SJ
    Biomed Pharmacother; 2019 Oct; 118():109250. PubMed ID: 31545242
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Long noncoding RNA CRCMSL suppresses tumor invasive and metastasis in colorectal carcinoma through nucleocytoplasmic shuttling of HMGB2.
    Han Q; Xu L; Lin W; Yao X; Jiang M; Zhou R; Sun X; Zhao L
    Oncogene; 2019 Apr; 38(16):3019-3032. PubMed ID: 30575817
    [TBL] [Abstract] [Full Text] [Related]  


    of 2.